Closing Bell: Medexus Pharmaceuticals Inc down on Tuesday (MDP)

In today's trading, Medexus Pharmaceuticals Inc stock opened at $2.27 and closed at $2.23. prices ranged from a low of $2.15 to a high of $2.27.

Share prices dipped -2.19% from the previous day's close of $2.28.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

A total of 15,605 shares was traded during the last trading day, with total trades of 45, with an average volume of 19,757 over the last 5 days.

Trading across the entire TSX saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, in the last 12 months, Medexus Pharmaceuticals Inc's shares have dipped -23.10%, while in 2024, they have dipped -9.72%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $55.77 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Based on 4.00 analysts, Medexus Pharmaceuticals Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..